Combining TGF-β inhibition and angiotensin II blockade results in enhanced antifibrotic effect
- 1 November 2004
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 66 (5), 1774-1784
- https://doi.org/10.1111/j.1523-1755.2004.00901.x
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Transforming growth factor-β suppresses macrophage-induced mesangial cell fibronectin expressionKidney International, 2001
- Transforming growth factor-beta1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstructionKidney International, 2000
- Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritisKidney International, 2000
- Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritisKidney International, 2000
- Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in miceJCI Insight, 1999
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Abnormal Regulation of Transforming Growth Factor-β Receptors on Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats by Angiotensin IIHypertension, 1998
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.JCI Insight, 1994
- Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.JCI Insight, 1994
- The Progression of Renal DiseaseNew England Journal of Medicine, 1988